INOZYME PHARMA INC (INZY)
US45790W1080 - Common Stock
ChartMill assigns a Buy % Consensus number of 86% to INZY. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 21.42. This target is 354.78% above the current price.
INZY was analyzed by 13 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about INZY.
In the previous month the buy percentage consensus was at a similar level.
INZY was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-10 | Needham | Reiterate | Buy -> Buy |
| 2024-04-09 | Needham | Reiterate | Buy -> Buy |
| 2024-04-09 | B of A Securities | Maintains | Buy -> Buy |
| 2024-03-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-12 | Needham | Reiterate | Buy -> Buy |
| 2024-01-30 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-11-08 | Needham | Reiterate | Buy -> Buy |
| 2023-09-27 | Needham | Reiterate | Buy -> Buy |
| 2023-09-08 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-08-09 | Needham | Reiterate | Buy -> Buy |
| 2023-08-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-07-27 | Needham | Reiterate | Buy -> Buy |
| 2023-05-10 | Needham | Reiterate | Buy |
| 2023-04-19 | Needham | Reiterate | Buy |
| 2023-03-23 | Needham | Reiterate | Buy |
| 2023-03-23 | Jefferies | Upgrade | Hold -> Buy |
| 2023-02-17 | Needham | Reiterate | Buy |
| 2023-02-17 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-05-26 | Jefferies | Initiate | Hold |
| 2022-05-11 | HC Wainwright & Co. | Maintains | Buy |
| 2022-02-07 | HC Wainwright & Co. | Initiate | Buy |
| 2021-11-29 | Needham | Initiate | Buy |